Navigating Complexities In Randomized Trials: Insights From The EMERGE Trial Amidst Pandemic And Cybersecurity Threat
Rattachement africain : ie. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Introduction: The COVID-19 pandemic caused by the SARS-CoV-2 virus changed the global landscape of clinical trials; changes in staffing, clinical priorities and recruitment challenges led to the delay or termination of many clinical trials. The Early Metformin in Gestational Diabetes (EMERGE) trial was completed despite COVID-19 and institutional computer network attacks (CNAs). Methods: Here we outline the challenges encountered and the solutions employed to continue the active recruitment of a potentially high risk patient cohort during the Covid-19 pandemic and detail the techniques adapted to enable recruitment, adverse event reporting and lab reporting during two critical computer network attacks. We present our solutions from both the site and sponsor perspective. Results: COVID-19 and the computer network attacks presented many challenges for the clinical trial site and Sponsor including staff shortages, remote working, deferred recruitment, changes in the diagnostic pathway for gestational diabetes mellitus and pivoting to remote working and telemedicine. The first CNA impeded clinical and laboratory systems, impacting recruitment and follow up. The second CNA delayed access to the Clinical Data Management System. Solutions employed included telemedicine, videoconferencing, shortened in-person reviews, contact tracing, COVID-19 risk mitigations, paper-based back-up systems and vigorous data integrity checks. Conclusion: Overcoming the multiple challenges posed by COVID-19 and computer network attacks required rapid re-organisation, teamwork and flexibility from staff and Sponsor. The use of both digital solutions and paper-based records highlighted the importance of rapid innovation and comprehensive protocol planning.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Navigating Complexities In Randomized Trials: Insights From The EMERGE Trial Amidst Pandemic And Cybersecurity Threat
- Date Crossref
- 10/09/2025
- Éditeur
- F1000 Research Ltd
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Ollscoil na Gaillimhe – University of Galway pays non établi dans la noticeUniversité ou école supérieure
-
University Hospital Galway pays non établi dans la noticeÉtablissement de santé
-
COPE Galway pays non établi dans la noticeInstitution
-
Trials Methodology Research Network pays non établi dans la noticeStructure de recherche
-
College of nursing pays non établi dans la noticeUniversité ou école supérieure
-
Galway University Hospital pays non établi dans la noticeUniversité ou école supérieure
-
HRB Clinical Research Facility pays non établi dans la noticeÉtablissement de santé
-
School of Nursing and Midwifery pays non établi dans la noticeUniversité ou école supérieure
-
School of Business and Economics pays non établi dans la noticeUniversité ou école supérieure
Ollscoil na Gaillimhe – University of Galway, University Hospital Galway et COPE Galway, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.